chr1-218424517-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001135599.4(TGFB2):​c.595-9565C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.227 in 152,200 control chromosomes in the GnomAD database, including 4,395 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4395 hom., cov: 32)

Consequence

TGFB2
NM_001135599.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.487

Publications

13 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.534 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001135599.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.511-9565C>T
intron
N/ANP_003229.1
TGFB2
NM_001135599.4
c.595-9565C>T
intron
N/ANP_001129071.1
TGFB2
NR_138148.2
n.1877-9565C>T
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.511-9565C>T
intron
N/AENSP00000355897.4
TGFB2
ENST00000366929.4
TSL:1
c.595-9565C>T
intron
N/AENSP00000355896.4
TGFB2
ENST00000488793.1
TSL:3
n.175-9565C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.227
AC:
34580
AN:
152082
Hom.:
4389
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.159
Gnomad AMI
AF:
0.339
Gnomad AMR
AF:
0.321
Gnomad ASJ
AF:
0.242
Gnomad EAS
AF:
0.552
Gnomad SAS
AF:
0.291
Gnomad FIN
AF:
0.246
Gnomad MID
AF:
0.193
Gnomad NFE
AF:
0.214
Gnomad OTH
AF:
0.228
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.227
AC:
34594
AN:
152200
Hom.:
4395
Cov.:
32
AF XY:
0.232
AC XY:
17277
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.159
AC:
6592
AN:
41522
American (AMR)
AF:
0.321
AC:
4910
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.242
AC:
840
AN:
3472
East Asian (EAS)
AF:
0.551
AC:
2851
AN:
5172
South Asian (SAS)
AF:
0.290
AC:
1400
AN:
4820
European-Finnish (FIN)
AF:
0.246
AC:
2601
AN:
10584
Middle Eastern (MID)
AF:
0.184
AC:
54
AN:
294
European-Non Finnish (NFE)
AF:
0.214
AC:
14554
AN:
68014
Other (OTH)
AF:
0.228
AC:
483
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1347
2694
4040
5387
6734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.225
Hom.:
16178
Bravo
AF:
0.234
Asia WGS
AF:
0.356
AC:
1237
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.49
DANN
Benign
0.65
PhyloP100
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1342586; hg19: chr1-218597859; API